Virtual Reality for Pain and Anxiety Distraction Strategy on Office Hysteroscopy
VRPAD
Effectiveness of Virtual Reality as a Pain and Anxiety Distraction Strategy on Office Hysteroscopy
1 other identifier
interventional
160
1 country
1
Brief Summary
Hysteroscopy is a minimally invasive endoscopic technique that allows direct visualization of the uterine cavity and constitutes the gold standard for the diagnosis and treatment of most intrauterine pathology, such as heavy menstrual bleeding, fibroids, endometrial polyps, uterine malformations, etc. The "see and treat" strategy allows diagnosis and treatment in the same surgical act, and gives the technique a high resolution capacity, reducing the number of procedures the patient must undergo. The technological development of instruments has made it possible to have small-caliber endoscopic systems that have made this technique possible in an outpatient setting. Outpatient management allows patients to avoid the possible risks and inconveniences associated with the surgical environment, such as the waiting list and the need for anesthesia, as well as an earlier return to their activities of daily life. Despite the high resolution rates, a not inconsiderable percentage of women experience anxiety or pain during outpatient hysteroscopy, and this is the leading cause of treatment failure. In order to improve the tolerance and comfort of the patient, the usefulness of various strategies, both pharmacological and non-pharmacological, has been evaluated for pain reduction, with different results. Virtual Reality (VR) has been used successfully to reduce perceived pain in various procedures such as chronic pain, burns, dental processes, chronic pruritus or venipuncture. There is no published study to our knowledge that evaluates the usefulness of VR in reducing the levels of anxiety and pain perceived during a hysteroscopic procedure. The working hypothesis to be evaluated with this study is that the use of a VR device with reproduction of relaxing and distraction environments reduces the perception of pain and anxiety of the patient during an outpatient hysteroscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 18, 2020
CompletedFirst Submitted
Initial submission to the registry
December 11, 2020
CompletedFirst Posted
Study publicly available on registry
January 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedDecember 20, 2023
January 1, 2021
3.4 years
December 11, 2020
December 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain score
Decrease of 1 point or more in the level of pain measured by an 11-point visual analog scale, a validity scale that comprises 11 consecutive values from 0 to 10, with "0" corresponding to no pain and "10" to worst pain imaginable.
Intraprocedure
Secondary Outcomes (3)
Heart Rate
Intraprocedure
Blood Pressure
Intraprocedure
Skin conductace
Intraprocedure
Study Arms (2)
Standard of care
NO INTERVENTIONOffice hysteroscopy performed as the standard of care of our Hospital
Virtual Reality
EXPERIMENTALOffice hysteroscopy with the use of VR environment (preprocedure and during procedure)
Interventions
The patients of the VR Group will be subjected to the same hysteroscopy technique as the Standard of Care Group, but additionally a VR device will be applied where a distraction VR environment ("Underwater Game") will be reproduced during the exploration
Eligibility Criteria
You may qualify if:
- Being over 18 years
- Understand and accept the study procedures
- Sign the informed consent.
- Indication of outpatient hysteroscopy according to the care protocols of the center
- Not taking drugs for the treatment of anxiety.
You may not qualify if:
- Not being able to understand the nature of the study and / or the procedures to be followed
- Not signing the informed consent
- Be under the age of 18
- Pregnancy
- Being diagnosed with anxiety disorder or being treated with anxiolytics
- Patients suffering from vertigo
- Patients with epilepsy
- Active ear infection
- Patients with diagnosed hypertension
- Patients with cardiovascular disease
- Patients with psychosis or severe mental illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Josep Estadella Tarriel
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 11, 2020
First Posted
January 22, 2021
Study Start
February 18, 2020
Primary Completion
June 30, 2023
Study Completion
June 30, 2023
Last Updated
December 20, 2023
Record last verified: 2021-01